...Therapeutics Inc. Heat shock transcription factor 1 (HSF1) agonist Small molecule activators of HSF1 Preclinical Medesis Pharma...

...for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation to Medesis'...
...formulation technology is in preclinical testing. Medesis hopes to start Phase I/II testing in mid-2010. Medesis Pharma...